How I diagnose and treat neutropenia
DC Dale - Current opinion in hematology, 2016 - journals.lww.com
How I diagnose and treat neutropenia : Current Opinion in Hematology How I diagnose and
treat neutropenia : Current Opinion in Hematology Log in or Register Subscribe to journalSubscribe …
treat neutropenia : Current Opinion in Hematology Log in or Register Subscribe to journalSubscribe …
Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation
M Schmidt-Hieber, D Teschner… - Expert review of anti …, 2019 - Taylor & Francis
Introduction: Infections are among the most frequent complications in patients with
hematological and oncological diseases. They might be classified as fever of unknown …
hematological and oncological diseases. They might be classified as fever of unknown …
[HTML][HTML] Markers of intestinal mucositis to predict blood stream infections at the onset of fever during treatment for childhood acute leukemia
Despite chemotherapy-induced intestinal mucositis being a main risk factor for blood stream
infections (BSIs), no studies have investigated mucositis severity to predict BSI at fever onset …
infections (BSIs), no studies have investigated mucositis severity to predict BSI at fever onset …
Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropenia
C Fontanella, S Bolzonello, B Lederer, G Aprile - Breast care, 2014 - karger.com
Chemotherapy-induced neutropenia (CIN) is a common toxicity caused by the
administration of anticancer drugs. This side effect is associated with life-threatening …
administration of anticancer drugs. This side effect is associated with life-threatening …
[HTML][HTML] Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta …
Background Guidelines recommend primary prophylaxis (PP) with granulocyte-colony-
stimulating factors (G-CSF) for patients above a febrile neutropenia (FN) risk threshold of …
stimulating factors (G-CSF) for patients above a febrile neutropenia (FN) risk threshold of …
New agents in multiple myeloma: an examination of safety profiles
S Bringhen, E De Wit, MA Dimopoulos - Clinical Lymphoma Myeloma and …, 2017 - Elsevier
Numerous treatments are available for relapsed and/or refractory multiple myeloma (MM),
with safety profiles varying across drug classes and across agents within the same class …
with safety profiles varying across drug classes and across agents within the same class …
Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells
A Somasundaram, AR Cillo, C Lampenfeld… - Cancer immunology …, 2022 - AACR
Many cancer patients do not develop a durable response to the current standard-of-care
immunotherapies, despite substantial advances in targeting immune inhibitory receptors. A …
immunotherapies, despite substantial advances in targeting immune inhibitory receptors. A …
Management of patients with fever and neutropenia through the arc of time: a narrative review
PA Pizzo - Annals of Internal Medicine, 2019 - acpjournals.org
The association between fever and neutropenia and the risk for life-threatening infections in
patients receiving cytotoxic chemotherapy has been known for 50 years. Indeed, infectious …
patients receiving cytotoxic chemotherapy has been known for 50 years. Indeed, infectious …
Effect of neutropenic diet on infection rates in cancer patients with neutropenia: a meta-analysis of randomized controlled trials
Results: Five randomized controlled trials with a total of 388 patients were included in the
final analysis. Patients mostly had acute myeloid leukemia (AML), acute lymphoblastic …
final analysis. Patients mostly had acute myeloid leukemia (AML), acute lymphoblastic …
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
D Clerici, L Galli, R Greco, AP Lugli, F Erbella… - Blood …, 2023 - ashpublications.org
Fluoroquinolone prophylaxis's (FQ-P) usefulness in patients with neutropenia is
controversial. In recent decades, Italian epidemiological data has shown worrisome rates of …
controversial. In recent decades, Italian epidemiological data has shown worrisome rates of …